Featured

To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this fall. The next round of COVID booster shots should contain a component that combats the...

Combining the power of network with data paves the way for better logistical support for healthcare players.  The latest wave of COVID-19 infections has made its way across East Asia, with Hong Kong, Shanghai and Beijing, reporting record numbers...

A novel 3D printed methodology for extracting stem cells from bioreactors has been created by researchers at the University of Technology, Sydney, opening the door to the possibility of high-quality, mass-produced stem cells in Australia at a cheaper price. Due...

Novartis has committed to investing $250 million in research and development over the next five years in an effort to find a cure for malaria and other neglected tropical diseases (NTDs). CEO Vas Narasimhan remarked in a statement that...

In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion over 10 years. This research will focus on novel and ground-breaking vaccines and medications to diagnose...

No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what’s the best approach to retaining the product’s stability? The answer is critically important from your very...

In the pharmaceutical industry and other consumer markets that produce and sell hazardous substances, child-resistant packaging has become an essential element of packaging design. As legislation and regulations increase all around the world and more firms take the moral pledge...